CN105998164A - Traditional Chinese medicine composition and granules for treating atopic dermatitis and preparation method - Google Patents

Traditional Chinese medicine composition and granules for treating atopic dermatitis and preparation method Download PDF

Info

Publication number
CN105998164A
CN105998164A CN201610443314.8A CN201610443314A CN105998164A CN 105998164 A CN105998164 A CN 105998164A CN 201610443314 A CN201610443314 A CN 201610443314A CN 105998164 A CN105998164 A CN 105998164A
Authority
CN
China
Prior art keywords
succinum
chinese medicine
calculus bovis
radix glycyrrhizae
glycyrrhizae extractum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610443314.8A
Other languages
Chinese (zh)
Other versions
CN105998164B (en
Inventor
蔡瑞康
袁海龙
吴燕
沈成英
徐荣
张思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PLA AIR FORCE GENERAL HOSPITAL
Original Assignee
PLA AIR FORCE GENERAL HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PLA AIR FORCE GENERAL HOSPITAL filed Critical PLA AIR FORCE GENERAL HOSPITAL
Priority to CN201610443314.8A priority Critical patent/CN105998164B/en
Publication of CN105998164A publication Critical patent/CN105998164A/en
Application granted granted Critical
Publication of CN105998164B publication Critical patent/CN105998164B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10Peat; Amber; Turf; Humus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a traditional Chinese medicine composition and granules for treating atopic dermatitis and a preparation method, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from calculus bovis factitius, amber and a licorice root extract, and the weight ratio of calculus bovis factitius to amber to licorice root extract is 3:10:2. The traditional Chinese medicine composition granules comprise active ingredients and a pharmaceutically acceptable carrier, wherein the active ingredients comprise calculus bovis factitius, amber and licorice root extract, and the weight ratio of calculus bovis factitius to amber to licorice root extract is 3:10:2. The traditional Chinese medicine composition and granules for treating the atopic dermatitis and the preparation method have the following advantages that the ingredients are simple and effective and can effectively treat the atopic dermatitis; the problems that amber is difficult to dissolve, and a gravel feeling exists can be effectively solved by adopting a nano suspension technology.

Description

A kind of Chinese medicine composition treating atoipc dermatitis and granule thereof and preparation method
Technical field
The invention belongs to technical field of Chinese medicine, be specifically related to a kind of Chinese medicine composition treating atoipc dermatitis and granule thereof Agent and preparation method.
Background technology
Atoipc dermatitis system betides a kind of inflammatory dermatoses at seborrhea position, and reason is the most clear.Infection, essence God factor, dietary habit, sleep, Exposure to Sunlight etc. all can affect the development of primary disease, there is no specific short at present, the most right Disease is treated.
Summary of the invention
The traditional Chinese medical science thinks that atoipc dermatitis is damp and hot excessive or insufficiency of the spleen wet caused, the rule for the treatment of with heat clearing away, removing heat from blood, dampness removing or heat clearing away, Spleen invigorating, removing dampness, to dispel the wind, moisturize be main.The present inventor according to the test repeatedly of the research of theory of Chinese medical science and clinic and checking, Finally have found the medicine effectively treating atoipc dermatitis, thus complete the present invention.Medicine of the present invention is to select artificial cattle Huang, succinum and Radix Glycyrrhizae extractum.Calculus Bovis nature and flavor are sweet cool, have the effect of heat clearing away, removing toxic substances, removing heat from blood, can be used for treating carbuncle Sore, also have be in harmonious proportion the property of medicine effect, succinum have calm the nerves antipruritic, the effect of clearing away heat and cooling blood, the cortex that Radix Glycyrrhizae has Hormone-like effect is also helpful to treatment atoipc dermatitis.Three medicines share, and play the effect of heat clearing away, removing heat from blood, dampness removing altogether.
It is an object of the invention to disclose a kind of Chinese medicine composition treating atoipc dermatitis.
Second object of the present invention is to disclose a kind of Chinese medicine granules treating atoipc dermatitis.
Third object of the present invention is to disclose the preparation method of a kind of Chinese medicine granules treating atoipc dermatitis.
It is an object of the invention to be achieved through the following technical solutions:
A kind of Chinese medicine composition treating atoipc dermatitis, wherein, described Chinese medicine composition is by artificial Calculus Bovis, succinum and sweet Grass extractum composition, the weight ratio of each composition is artificial Calculus Bovis: succinum: Radix Glycyrrhizae extractum=3:10:2.
A kind of Chinese medicine granules treating atoipc dermatitis, including active component and pharmaceutically acceptable carrier, wherein, Described active component is made up of artificial Calculus Bovis, succinum and Radix Glycyrrhizae extractum, and the weight ratio of each composition is artificial Calculus Bovis: succinum: Radix Glycyrrhizae Extractum=3:10:2.
Chinese medicine granules described in technique scheme, wherein, described pharmaceutically acceptable carrier is dextrin.
A kind of Chinese medicine composition treating atoipc dermatitis, wherein, described Chinese medicine composition is by artificial Calculus Bovis, succinum and sweet Grass extractum composition, the weight ratio of each composition is artificial Calculus Bovis: succinum: Radix Glycyrrhizae extractum=3:10:2.
A kind of Chinese medicine granules treating atoipc dermatitis, including active component and pharmaceutically acceptable carrier, wherein, Described active component is made up of artificial Calculus Bovis, succinum and Radix Glycyrrhizae extractum, and the weight ratio of each composition is artificial Calculus Bovis: succinum: Radix Glycyrrhizae Extractum=3:10:2.
Chinese medicine granules described in technique scheme, wherein, described pharmaceutically acceptable carrier is dextrin.
The preparation method of a kind of Chinese medicine granules treating atoipc dermatitis, comprises the steps:
(1), weighing active component and pharmaceutically acceptable carrier, wherein in active component, weight ratio between each raw material is Artificial Calculus Bovis: succinum: Radix Glycyrrhizae extractum=3:10:2;The equal grinds of artificial Calculus Bovis, succinum and Radix Glycyrrhizae extractum, crosses 100 mesh sieves, standby With;
(2), by the succinum in step (1), it is dispersed in water, enters wet milk, feed rate 80-120mL/min, rotating speed 2500-3000rpm/min, pressure is 0.4-0.6bar, grinds a few and obtains succinum nanosuspension;
(3), weigh the 1/3 of Radix Glycyrrhizae extractum powder total amount, add it to, in succinum nanosuspension, be sufficiently mixed, dissolve; Use pressure spray process at the bottom of fluid bed, with pharmaceutically acceptable carrier, remain 2/3 Radix Glycyrrhizae extractum powder, artificial Calculus Bovis's mixture For carrier, put it in fluidised bed material groove, extension set frequency 14.46Hz, inlet temperature 57.5-58 DEG C, material are set Temperature 40 DEG C, atomizing pressure 0.1MPa, peristaltic pump feed flow rotating speed 8r/min;After nanosuspension has sprayed, temperature 40 DEG C Under be dried 30min, take out.
(4), being sieved by above-mentioned granule oscillating sieving machine, upper sieve mesh is 16 mesh, and lower screen mesh is that 30 mesh sieves are received Collection granule, obtains granule.
Preparation method described in technique scheme, wherein, described pharmaceutically acceptable carrier is dextrin.
The present invention is made up of artificial Calculus Bovis, succinum, Radix Glycyrrhizae extractum three taste medicine, and wherein artificial Calculus Bovis is monarch, have heat clearing away, Removing toxic substances, the effect of removing heat from blood, can be used for treating skin sore, also have effect of the mediation property of medicine;Succinum have calm the nerves antipruritic, The effect of clearing away heat and cooling blood, for ministerial drug;The 17-hydroxy-11-dehydrocorticosterone sample effect that Radix Glycyrrhizae has is also helpful to treatment atoipc dermatitis. Three medicines share, and play the effect of heat clearing away, removing heat from blood, dampness removing altogether.
The Chinese medicinal granule of the present invention is administered orally, a 5g, three times on the one.
The dosage form of product of the present invention is granule, and character is the granule of lark;Taste is micro-sweet, and using method is oral, loading amount, Granularity, moisture, melting and limit test of microbe all meet to be had under Chinese Pharmacopoeia two annex granule items of version in 2015 Close regulation.
The method have the advantages that
1, the active component of medicine of the present invention is only made up of three taste medicines, and composition is simply effective, can effectively treat atoipc dermatitis.
2, the present invention uses nanometer suspension technology can effectively solve the problems such as the indissoluble of succinum, grittiness.
Accompanying drawing illustrates:
1, Fig. 1 is that thin layer chromatography is to the discriminating of artificial Calculus Bovis in Chinese medicine granules;
2, Fig. 2 is that thin layer chromatography is to the discriminating of Radix Glycyrrhizae extractum in Chinese medicine granules.
Detailed description of the invention:
For making technical scheme readily appreciate, below in conjunction with concrete test example, one of the present invention is treated atopy skin Scorching Chinese medicine composition and granule and preparation method thereof are further described, and in the present invention, raw material is market purchase.
Embodiment 1:A kind of Chinese medicine composition treating atoipc dermatitis:
Weigh artificial Calculus Bovis 90g, succinum 300g, Radix Glycyrrhizae extractum 60g, above-mentioned raw materials is clayed into power, in i.e. obtaining after mixing Drug composition.
Embodiment 2:A kind of Chinese medicine granules treating atoipc dermatitis:
(1), with weight proportion be artificial Calculus Bovis 90g, succinum 300g, Radix Glycyrrhizae extractum 60g, dextrin 550g weighting raw materials And adjuvant, by equal to artificial Calculus Bovis, succinum and Radix Glycyrrhizae extractum grinds, cross 100 mesh sieves, standby;
(2), by the succinum in step (1), after being scattered in suitable quantity of water, enter wet milk, feed rate 80-120ml/min, turn Speed 2500-3000rpm/min, pressure is 0.4-0.6bar, grinds a few and obtains succinum nanosuspension;
(3), weigh 20g Radix Glycyrrhizae extractum powder, add it to, in succinum nanosuspension, be sufficiently mixed, dissolve;Use Pressure spray process at the bottom of fluid bed, with 550g dextrin, residue 40g Radix Glycyrrhizae extractum powder, 90g artificial Calculus Bovis's mixture as carrier, will It puts into fluidised bed material groove, arrange extension set frequency 14.46Hz, inlet temperature 57.5-58 DEG C, temperature of charge 40 DEG C, Atomizing pressure 0.1MPa, peristaltic pump feed flow rotating speed 8r/min etc..After nanosuspension has sprayed, it is dried 30min (temperature 40 DEG C), take out;
(4), being sieved by above-mentioned granule oscillating sieving machine, upper sieve mesh is 16 mesh, and lower screen mesh is that 30 mesh sieves are received Collection granule, obtains granule.
Below by way of series of experiments illustrate product of the present invention a kind of treat atoipc dermatitis Chinese medicine granules (hereinafter referred to as: Antipyretic and itching-stopping granule) relatively reasonable and there is higher safety and good clinical treatment in terms of preparation prescription composition Effect.Experiment content is as follows:
Experimental example 1:Quality standard research of the present invention:
Differentiate:
(1), Example 2 prepare product 2g, finely ground, add chloroform 20ml, shaking is dissolved, and filters, and filtering residue is for mirror Not (2) use.Filtrate is evaporated, and adds ethanol 0.5ml and makes dissolving, as need testing solution.Separately take cholic acid reference substance appropriate, Add ethanol and make every 1ml solution containing 1mg, as reference substance solution.According to thin layer chromatography (" Chinese Pharmacopoeia " 2015 Version general rule 0502) test, draw each 5 μ 1 of above two solution, put respectively on same silica gel g thin-layer plate, with n-hexane The upper solution of-ethyl acetate-acetic acid-methanol (20:25:2:3) is developing solvent, launches, and takes out, dries, and spray is with 10% sulphuric acid Ethanol solution, heats about 10 minutes at 105 DEG C, puts and inspect under ultra-violet lamp (365nm), and result is as it is shown in figure 1, supply examination In product chromatograph, on position corresponding with reference substance chromatograph, the fluorescence speckle of aobvious same color, wherein Fig. 11 is classified as Cholic acid reference substance, 2~4 are classified as three batches of test samples, the 5 negative solution being classified as scarce artificial Calculus Bovis.
(2), the residue that takes under discriminating (1) item, volatilize chloroform, add water 20ml, stirring, centrifugal, point takes supernatant, With n-butanol extraction 2 times, each 20ml (is centrifuged) if desired, merges n-butanol extracting liquid, puts and be evaporated in water-bath, residue Add methanol 1ml and make dissolving, as need testing solution.Another extracting liquorice control medicinal material 0.5g, adds methanol 15ml, supersound process 15 minutes, filtering, filtrate is concentrated into 1ml, as control medicinal material solution.According to thin layer chromatography (" Chinese Pharmacopoeia " 2015 Version general rule 0502) test, draw each 5 μ 1 of above two solution, put the silica gel G prepared in same 1%NaOH liquid respectively On lamellae, with acetic ether-methanoic acid-glacial acetic acid-water (15:1:1:2) as developing solvent, launching, take out, dry, spray is with 10% Ethanol solution of sulfuric acid, is heated to spot development at 105 DEG C clear.Put and inspect under ultra-violet lamp (365nm), result such as Fig. 2 Shown in, in test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious identical orange-yellow fluorescence speckle, wherein In Fig. 2 row 1 be Radix Glycyrrhizae reference substance, row 2~4 be three batches of test samples, row 5 be the negative solution lacking Radix Glycyrrhizae extractum.
[assay] measures according to high performance liquid chromatography (" Chinese Pharmacopoeia " 2015 editions general rules 0512)
Chromatographic condition and system suitability are with octadecylsilane chemically bonded silica as filler, with acetonitrile-1% ice vinegar Acid (90:10) is flowing phase;Detection wavelength is 450nm.Number of theoretical plate is calculated by bilirubin should be not less than 3000.
It is appropriate that the preparation of reference substance solution takes bilirubin reference substance, and accurately weighed, adding methylene chloride to make in every 1ml contains The solution of 10 μ g, to obtain final product.
The preparation of need testing solution takes this product about 2g, accurately weighed, puts in tool plug conical flask, accurate addition 0.2mol/l Calcium Disodium Versenate solution (suitably heat during preparation and make to be completely dissolved, let cool, face by brand-new) 5ml, accurate addition Water saturation dichloromethane 50ml, weighed weight, supersound process (ice bath) 30 minutes, put to room temperature, more weighed weight, use Water saturation dichloromethane supplies the weight of less loss, shakes up, centrifugal, takes dichloromethane solution, filters, and precision measures subsequent filtrate 5ml, puts in 10ml measuring bottle, adds dehydrated alcohol dilution and is settled to scale, and mixing to obtain final product.
Algoscopy precision respectively draws reference substance solution and each 20 μ l of need testing solution, injects chromatograph of liquid, measures, Obtain.
The every g of this product contains artificial Calculus Bovis with bilirubin (C33H36N4O6) meter, 0.2mg must not be less than.
Test example 2:Acute toxicity test of the present invention:
One, test objective:
Observe animal subject after giving maximum volume and maximal dose antipyretic and itching-stopping granule, institute under not producing death condition The toxic reaction produced.
Two, test material and method
1, animal and rearing conditions: Switzerland's Kunming outbred mice, body weight 18-22g, for 20, male and female half and half, by Military Medical Science Institute's animal center provides.Animal House temperature 25 ± 3 DEG C, 12 hours bright, and 12 hours dark.Animal divides cage Raise, 10, every cage, free diet and drinking-water.Animal starts test after adapting to 3 days.
2, medicine and preparation: antipyretic and itching-stopping granule, dissolves with distilled water before using, and embodiment 2 prepares gained.
3, dosage and route of administration: 8.3g/kg, 0.8ml/, gavage.
4, observation index: after administration, every day observes the poisoning manifestations of animal, Continuous Observation 7 days.
Three, result:
Do not observe that animal has Novel presentation.
Four, conclusion:
1, Mouse oral antipyretic and itching-stopping granule 8.3g/kg performance without exception.
2, antipyretic and itching-stopping granule is administered orally the maximum tolerated dose (MTD) of mice is 8.3g/kg, is equivalent to adult every for every day 100 times of secondary oral dose.
Test example 3: the present invention treats atoipc dermatitis clinical trial:
The Chinese medicine granules (antipyretic and itching-stopping granule) that the embodiment of the present invention 2 prepares gained is main containing Calculus Bovis, succinum and Radix Glycyrrhizae Extractum, has heat clearing away, removing toxic substances, removing heat from blood, antipruritic effect of calming the nerves.The method using opening experiment observes this medicine to 50 The curative effect of example patients with atopic dermatitis, is now reported as follows.
One, case and method:
1, case selection:
(1), inclusion criteria: the patients with atopic dermatitis made a definite diagnosis according to typical clinical symptoms and sign, the age is at 14-60 Year, and do not take in one week or external used medicine person.
(2), exclusion standard:
1. gestation and women breast-feeding their children.
2. serious hepatic and kidney function obstacle.
3. neuropsychopathy is suffered from and noncooperationist.
4. allergy or be not resistant to person.
(3), standard is rejected:
The most all uncooperative, the most do not complete person's course for the treatment of.
2. after medication, occur that serious adverse reaction is forced therapy discontinued person.
2, test method:
(1), research method: use random opening method.
(2), medicine for treatment (antipyretic and itching-stopping granule).
1. medicament composing prescription: Calculus Bovis, succinum, Radix Glycyrrhizae extractum.
2. packaging: powder, 5 grams/bag.
(3), Therapeutic Method:
1. have a blood test respectively before and after treatment, routine urinalysis, ALT, AST and BUN, CR.
It is administered orally two bags, every twice-daily the most every time.
Taking medicine the most continuously 15 days is a course for the treatment of.Therapeutic evaluation is made after two courses for the treatment of.
(4), untoward reaction observe, notes observation untoward reaction, and is recorded in detail.
(5), curative effect determinate standard
Recovery from illness: deflorescence >=90%, without new breakout;
Effective: deflorescence<90%,>=60%;
Effective: deflorescence<60%,>=20%;
Invalid: deflorescence < 20%.
Two, result:
1, physical data: observe 50 examples altogether, the ordinary circumstance of patient is shown in Table 1.
The basic condition of table 1 patient
2, severity extent: be shown in Table 2.
Table 2 conditions of patients degree
3, Chinese medical discrimination situation: be shown in Table 3
Table 3 patient's Chinese medical discrimination situation
4, the medicine impact on lab index: such as table 4, being worth before and after lab index treatment, (T value is through T inspection 12.67), P > 0.05, before and after showing treatment, difference is not notable, shows that two medicines are the safest.
The impact (x ± s n=30) on lab index of table 4 medicine
5, efficacy determination: as shown in table 5.
Table 5 observation of curative effect
6, untoward reaction: 50 examples have no adverse reaction.
Three, discuss:
Atoipc dermatitis system betides a kind of diseases associated with inflammation at seborrhea position, and reason is the most clear.Infection, spirit Factor, dietary habit, sleep, Exposure to Sunlight etc. all can affect it and develop, and there is no specific short at present, generally suits the medicine to the illness Treatment.The traditional Chinese medical science thinks that it is caused by damp and hot excessive or insufficiency of the spleen endogenous dampness, the rule for the treatment of with clearing away heat and cooling blood, dampness removing or heat clearing away, spleen invigorating, Removing dampness, wind dispelling, to moisturize be main.Antipyretic and itching-stopping granule is mainly composed of Calculus Bovis, succinum and Radix Glycyrrhizae extractum, and Calculus Bovis has clearly Heat, removing toxic substances, the effect of removing heat from blood, succinum have calm the nerves antipruritic, the effect of clearing away heat and cooling blood, Radix Glycyrrhizae extractum have QI invigorating invigorating middle warmer, Eliminating fire and detoxication, the effects such as the property of medicine that are in harmonious proportion.Our observation shows that this medicine has good therapeutic effect, total effective rate to atoipc dermatitis Reaching 74%, especially to dialectical evident in efficacy for heat symptom-complex person, observed 13 examples are all fully recovered.One of the present invention treats atopy skin Scorching Chinese medicine granules is easy to use, have no side effect, curative effect is high, is the preferable selection for the treatment of atoipc dermatitis.
The above, only presently preferred embodiments of the present invention, not the present invention is made any formal and substantial restriction, All those skilled in the art, in the range of without departing from technical solution of the present invention, when available disclosed above skill Art content, and a little change made, the equivalent variations modifying and develop, be the Equivalent embodiments of the present invention;Meanwhile, The change of any equivalent variations that above example is made by all substantial technological according to the present invention, modify and develop, the most still Belong in the range of technical scheme.

Claims (5)

1. the Chinese medicine composition treating atoipc dermatitis, it is characterised in that described Chinese medicine composition by artificial Calculus Bovis, Succinum and Radix Glycyrrhizae extractum composition, the weight ratio of each composition is artificial Calculus Bovis: succinum: Radix Glycyrrhizae extractum=3:10:2.
2. treating a Chinese medicine granules for atoipc dermatitis, including active component and pharmaceutically acceptable carrier, it is special Levying and be, described active component is made up of artificial Calculus Bovis, succinum and Radix Glycyrrhizae extractum, and the weight ratio of each composition is artificial Calculus Bovis: Succinum: Radix Glycyrrhizae extractum=3:10:2.
Chinese medicine granules the most according to claim 2, it is characterised in that: described pharmaceutically acceptable carrier is for sticking with paste Essence.
4. treat a preparation method for the Chinese medicine granules of atoipc dermatitis, comprise the steps:
(1), weighing active component and pharmaceutically acceptable carrier, wherein in active component, weight ratio between each raw material is Artificial Calculus Bovis: succinum: Radix Glycyrrhizae extractum=3:10:2;The equal grinds of artificial Calculus Bovis, succinum and Radix Glycyrrhizae extractum, crosses 100 mesh sieves, standby With;
(2), by the succinum in step (1), it is dispersed in water, enters wet milk, feed rate 80-120mL/min, rotating speed 2500-3000rpm/min, pressure is 0.4-0.6bar, grinds a few and obtains succinum nanosuspension;
(3), weigh the 1/3 of Radix Glycyrrhizae extractum powder total amount, add it to, in succinum nanosuspension, be sufficiently mixed, dissolve; Use pressure spray process at the bottom of fluid bed, with pharmaceutically acceptable carrier, remain 2/3 Radix Glycyrrhizae extractum powder, artificial Calculus Bovis's mixture For carrier, put it in fluidised bed material groove, extension set frequency 14.46Hz, inlet temperature 57.5-58 DEG C, material are set Temperature 40 DEG C, atomizing pressure 0.1MPa, peristaltic pump feed flow rotating speed 8r/min;After nanosuspension has sprayed, temperature 40 DEG C Under be dried 30min, take out;
(4), being sieved by above-mentioned granule oscillating sieving machine, upper sieve mesh is 16 mesh, and lower screen mesh is that 30 mesh sieves are received Collection granule, obtains granule.
Preparation method the most according to claim 4, it is characterised in that: described pharmaceutically acceptable carrier is dextrin.
CN201610443314.8A 2016-06-20 2016-06-20 Traditional Chinese medicine composition for treating atopic dermatitis and granules and preparation method thereof Active CN105998164B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610443314.8A CN105998164B (en) 2016-06-20 2016-06-20 Traditional Chinese medicine composition for treating atopic dermatitis and granules and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610443314.8A CN105998164B (en) 2016-06-20 2016-06-20 Traditional Chinese medicine composition for treating atopic dermatitis and granules and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105998164A true CN105998164A (en) 2016-10-12
CN105998164B CN105998164B (en) 2020-03-17

Family

ID=57088051

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610443314.8A Active CN105998164B (en) 2016-06-20 2016-06-20 Traditional Chinese medicine composition for treating atopic dermatitis and granules and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105998164B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1736474A (en) * 2005-07-28 2006-02-22 凌沛学 Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof
CN101485779A (en) * 2009-02-12 2009-07-22 北京市石景山区老医药卫生工作者协会模式口中医医院 Medicinal composition for treating psoriasis as well as preparation method and quality detection method
CN102232937A (en) * 2010-04-30 2011-11-09 天津药物研究院 Nanometer preparation and preparation method thereof
CN103393981A (en) * 2013-07-31 2013-11-20 广州中医药大学第二附属医院 Chinese medicinal composition for treating atopic dermatitis and preparation method thereof
CN103533926A (en) * 2011-01-24 2014-01-22 安特里奥公司 Compositions of empty nanoparticles and their use for treating dermatological conditions
CN104940710A (en) * 2015-07-23 2015-09-30 彭雄彬 Traditional Chinese medicine Kangning composition comprising soncretio silicea bambusae for treating epilepsy, and preparation method thereof
CN105030901A (en) * 2015-09-02 2015-11-11 孙学明 Traditional Chinese medicine composition for treatment of skin diseases and application method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1736474A (en) * 2005-07-28 2006-02-22 凌沛学 Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof
CN101485779A (en) * 2009-02-12 2009-07-22 北京市石景山区老医药卫生工作者协会模式口中医医院 Medicinal composition for treating psoriasis as well as preparation method and quality detection method
CN102232937A (en) * 2010-04-30 2011-11-09 天津药物研究院 Nanometer preparation and preparation method thereof
CN103533926A (en) * 2011-01-24 2014-01-22 安特里奥公司 Compositions of empty nanoparticles and their use for treating dermatological conditions
CN103393981A (en) * 2013-07-31 2013-11-20 广州中医药大学第二附属医院 Chinese medicinal composition for treating atopic dermatitis and preparation method thereof
CN104940710A (en) * 2015-07-23 2015-09-30 彭雄彬 Traditional Chinese medicine Kangning composition comprising soncretio silicea bambusae for treating epilepsy, and preparation method thereof
CN105030901A (en) * 2015-09-02 2015-11-11 孙学明 Traditional Chinese medicine composition for treatment of skin diseases and application method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
庞晓文: "泛发性湿疹89例临床分析", 《中国麻风皮肤病杂志》 *

Also Published As

Publication number Publication date
CN105998164B (en) 2020-03-17

Similar Documents

Publication Publication Date Title
CN104274578B (en) A kind of Chinese medicine composition with inhibiting bacteria and diminishing inflammation effect and preparation method thereof
CN102085252B (en) Pharmaceutical composition for treating ulcerative colitis and colon-targeted micro-pill preparation thereof
CN103893246A (en) General flavanone capsule of desmodium styracifolium and preparation method and application thereof
CN108888670A (en) A kind of segmented intestine targeted capsule that treating ulcerative colitis and its preparation process
CN101019952B (en) Medicine for treating eczema and preparation process of its ointment
CN101366876A (en) Traditional Chinese medicine preparation for treating throat irritation and preparation method thereof
CN1733273B (en) Process for preparing the sanjin pharmaceutical agent
CN101288700A (en) Chinese medicinal composition and preparation method and quality control method thereof
CN107456491A (en) A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof
CN101584809B (en) Medicine for treating cold grasserie and method of preparing the medicine
CN108452009A (en) A kind of application including Common Leafflower Herb, rainbow conk, Radix Salviae Miltiorrhizae and the Chinese medicine composition of Asian puccoon in the drug for preparing treatment liver cancer
CN104940781A (en) Traditional Tibetan medicine composition for treating nervous system diseases and preparation method thereof
CN106535912B (en) Control pharmaceutical composition and its application of human body blood fat and body weight
CN113952419B (en) Pharmaceutical composition for chronic renal failure and preparation method and application thereof
CN102652819B (en) Fuyankang dispersible tablet and preparation method thereof
CN101590212A (en) Treatment mental sickness Chinese medicine composition and preparation method thereof, purposes and quality control
CN101147767B (en) Preparation method of medicinal composition for treating acne
CN105748652B (en) Serissa japonica capsule for treating gout and preparation method thereof
CN105998164A (en) Traditional Chinese medicine composition and granules for treating atopic dermatitis and preparation method
CN104324089A (en) Rhubarb total anthraquinone being stable and uniform in proportion of various components and composition thereof used in jaundice-eliminating treatment of viral hepatitis type B
CN102652774A (en) Drug composition for treating leukopenia and hypoimmunity caused by chemoradiotherapy and preparation method and quality detection method
CN108452008A (en) A kind of application including Common Leafflower Herb, rainbow conk, Radix Salviae Miltiorrhizae and the Chinese medicine composition of Asian puccoon in preparing the drug for inhibiting recurrence of PHC
CN101062260B (en) Granule for complementing Yin and preventing anxiety and its production method
CN102813873A (en) Traditional Chinese medicine composition for treating mental diseases, and preparation method, application and quality control thereof
CN101147766B (en) Medicinal composition for treating acne and preparation process thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant